Syndax Pharmaceuticals Inc (SNDX)

Nov 03, 2025

Syndax Pharmaceuticals Reports Strong Q3 2025 Growth - TipRanks

Nov 03, 2025

Nov 03, 2025

Syndax Pharmaceuticals (SNDX) Q3 2025 Earnings: Revenue Jumps 21% - GuruFocus

Nov 03, 2025

Nov 03, 2025

Syndax Pharmaceuticals Q3 2025 Earnings Call Transcript - MarketBeat

Nov 03, 2025

Nov 03, 2025

Transcript : Syndax Pharmaceuticals, Inc., Q3 2025 Earnings Call, Nov 03, 2025 - MarketScreener

Nov 03, 2025

Nov 03, 2025

Syndax Pharmaceuticals Q3 Earnings: EPS of -$0.70 Beats Estimate, Revenue of $45.9M Misses Estimate - GuruFocus

Nov 03, 2025

Nov 03, 2025

Syndax: Q3 Earnings Snapshot - News-Times

Nov 03, 2025

Nov 03, 2025

Syndax Pharmaceuticals Grows Revenue As Wall Street Stays Bullish - Finimize

Nov 03, 2025

Nov 03, 2025

Syndax Reports Third Quarter 2025 Financial Results and Provides Business Update - The Manila Times

Nov 03, 2025

Nov 03, 2025

Syndax Pharmaceuticals falls as Q3 revenue misses estimates - Investing.com

Nov 03, 2025

Nov 03, 2025

SNDX: Syndax Pharmaceuticals to Showcase Promising Data at ASH 2 - GuruFocus

Nov 03, 2025

Nov 03, 2025

Is Syndax Pharmaceuticals Inc. stock poised for growth2025 Technical Overview & Low Volatility Stock Recommendations - newser.com

Nov 03, 2025

Nov 03, 2025

Syndax to Host ASH Investor Event in Person and via Webcast on December 8, 2025 - The Manila Times

Nov 03, 2025

Nov 03, 2025

Syndax Announces Compelling Revuforj® (revumenib) and - GlobeNewswire

Nov 03, 2025

Nov 03, 2025

Syndax (NASDAQ: SNDX) to present Revuforj and Niktimvo data in 23 ASH 2025 abstracts - Stock Titan

Nov 03, 2025

Nov 03, 2025

How Syndax Pharmaceuticals Inc. stock performs in rate cut cycles2025 Risk Factors & Safe Swing Trade Setup Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Using Ichimoku Cloud for Syndax Pharmaceuticals Inc. technicals2025 Big Picture & Entry and Exit Point Strategies - newser.com

Nov 03, 2025

Nov 03, 2025

Leading vs lagging indicators on Syndax Pharmaceuticals Inc. performanceJuly 2025 Short Interest & Entry Point Confirmation Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Is Syndax Pharmaceuticals Inc. (1T3) stock undervalued by metricsMarket Activity Recap & Weekly Momentum Picks - newser.com

Nov 03, 2025

Nov 03, 2025

AlphaQuest LLC Sells 18,370 Shares of Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat

Nov 03, 2025

Nov 03, 2025

Applying Wyckoff theory to Syndax Pharmaceuticals Inc. stockBreakout Watch & Verified Technical Trade Signals - newser.com

Nov 03, 2025

Nov 03, 2025

Detecting support and resistance levels for Syndax Pharmaceuticals Inc.Jobs Report & Verified Swing Trading Watchlist - newser.com

Nov 03, 2025

Nov 03, 2025

Is it too late to sell Syndax Pharmaceuticals Inc.Weekly Trade Summary & Growth-Oriented Investment Plans - newser.com

Nov 03, 2025

Nov 03, 2025

Will Syndax Pharmaceuticals Inc. stock maintain momentum in 2025Portfolio Value Report & Accurate Trade Setup Notifications - newser.com

Nov 03, 2025

Nov 02, 2025

Is Syndax Pharmaceuticals Inc. stock reversal real or fakeMarket Trend Report & Community Verified Watchlist Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

How Syndax Pharmaceuticals Inc. stock performs in stagflationJuly 2025 Chart Watch & Verified Momentum Watchlists - newser.com

Nov 02, 2025

Nov 02, 2025

Is Syndax Pharmaceuticals Inc. showing signs of accumulationMarket Volume Summary & AI Driven Stock Movement Reports - newser.com

Nov 02, 2025

Nov 02, 2025

Syndax Pharmaceuticals (SNDX) Q3 Earnings Preview: Key Expectati - GuruFocus

Nov 02, 2025

Nov 02, 2025

Kura Oncology's Ziftomenib Poised For Differentiation (NASDAQ:KURA) - Seeking Alpha

Nov 02, 2025

Nov 02, 2025

How risky is Syndax Pharmaceuticals Inc. stock nowJuly 2025 Recap & Free Technical Pattern Based Buy Signals - newser.com

Nov 02, 2025

Nov 01, 2025

Y Intercept Hong Kong Ltd Makes New Investment in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat

Nov 01, 2025

Oct 31, 2025

B. Riley Issues Optimistic Estimate for SNDX Earnings - MarketBeat

Oct 31, 2025

Oct 31, 2025

Syndax Pharmaceuticals Inc (SNDX) Q3 2025 Earnings Report Preview: What To Expect - Yahoo Finance

Oct 31, 2025

Oct 31, 2025

Syndax Pharmaceuticals Inc (SNDX) Q3 2025 Earnings Report Previe - GuruFocus

Oct 31, 2025

Oct 31, 2025

Syndax Pharmaceuticals Hits Day Low at $13.03 Amid Price Pressure - Markets Mojo

Oct 31, 2025

Oct 31, 2025

Syndax Pharmaceuticals’ Promising AML Study Update: Key Insights for Investors - TipRanks

Oct 31, 2025

Oct 31, 2025

Is Syndax Pharmaceuticals Inc. (1T3) stock considered safe havenJuly 2025 Sentiment & Fast Moving Stock Watchlists - newser.com

Oct 31, 2025

Oct 31, 2025

Why Syndax Pharmaceuticals Inc. stock is rated strong buyJuly 2025 Selloffs & Weekly Momentum Picks - newser.com

Oct 31, 2025

Oct 30, 2025

Published on: 2025-10-30 09:56:20 - newser.com

Oct 30, 2025

Oct 30, 2025

Syndax Pharmaceuticals Launches Promising Phase 3 AML Study with Revumenib - MSN

Oct 30, 2025

Oct 30, 2025

Syndax Announces Participation in November Investor Conferences - The Manila Times

Oct 30, 2025

Oct 30, 2025

Is Syndax Pharmaceuticals Inc. (1T3) stock a buy during volatile marketsEarnings Risk Summary & Smart Investment Allocation Insights - newser.com

Oct 30, 2025

Oct 30, 2025

Syndax (Nasdaq: SNDX) to join fireside chats at UBS, Guggenheim, Stifel, Jefferies - Stock Titan

Oct 30, 2025